BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Macrophage stimulating protein (MSP; MST1); serine/threonine kinase 3 (STK3; MST2)

September 29, 2016 7:00 AM UTC

Mouse studies suggest combined inhibition of MSP and STK3 could help treat colitis, liver damage and liver fibrosis. In a mouse model of chemical-induced colitis, a dual MSP/STK3 inhibitor tool compou...